The aim of this study was to evaluate the effects of maxillary sinus floor elevation by a tissue-engineered bone complex with recombinant human bone morphogenetic protein-2 (rhBMP-2)-loaded porous calcium phosphate cement (CPC) scaffold and bone marrow stromal cells (bMSCs) in rabbits. bMSCs were cultured and osteogenically induced. The osteoblastic differentiation of expanded bMSCs was detected by alkaline phosphatase activity, and calcium deposits in vitro. Thirty-six rabbits were randomly allocated into week 2, 4 and 8 observation groups. At each time point, 24 maxillary sinus floor elevation surgeries in 12 rabbits were performed bilaterally and randomly implanted by (1) CPC materials alone (group A, n = 6), (2) rhBMP-2/CPC composite materials alone (group B, n = 6), (3) CPC/bMSCs complex (group C, n = 6) and (4) rhBMP-2/CPC/bMSCs complex (group D, n = 6). As for maxillary sinus floor elevation, rhBMP-2-loaded CPC could promote new bone formation as compared to CPC, while addition of bMSCs could further enhance its new bone formation and maturity significantly, as detected by histological findings, and fluorochrome labeling. Our data suggested that rhBMP-2/CPC possessed excellent osteoinductive ability, while combining with bMSCs could further promote new bone formation and maturation in maxillary sinus elevation.

1.
Boyne, P.J., S. Salina, A. Nakamura, F. Audia, S. Shabahang (2006) Bone regeneration using BMP-2 induction in hemimandibulectomy type defects of elderly sub-human primates. Cell Tissue Bank 7: 1–10.
2.
Comuzzi, L., E. Ooms, J.A. Jansen (2002) Injectable calcium phosphate cement as filler for bone defects around oral implants: an experimental study in goats. Clin Oral Implants Res 13: 304–311.
3.
Crane, G.M., S.L. Lshaug, A.G. Mikos (1995) Bone tissue engineering. Nat Med 1: 1322–1324.
4.
del Real, R.P., J.G. Wolke, M. Vallet-Regi, J.A. Jansen (2002) A new method to produce macropores in calcium phosphate cements. Biomaterials 23: 3673–3680.
5.
Drosse, I., E. Volkmer., R. Capanna, P. De Biase, W. Mutschler, M. Schieker (2008) Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 39: S9–S20.
6.
Fei, Z., Y. Hu, D. Wu, H. Wu, R. Lu, J. Bai, H. Song (2008) Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci Mater Med 19: 1109–1116.
7.
Friedman, C.D., P.D. Costantino, S. Takagi, L.C. Chow (1998) BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 43: 428–432.
8.
Giannoni, P., M. Mastrogiacomo, M. Alini, S.G. Pearce, A. Corsi, F. Santolini, A. Muraglia, P. Bianco, R. Cancedda (2008) Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regen Med 2: 253–262.
9.
Graziani, F., N. Donos, I. Needleman, M. Gabriele, T.M. Tonetti (2004) Comparison of implant survival following sinus floor augmentation procedures with implants placed in pristine posterior maxillary bone: a systematic review. Clin Oral Implants Res 15: 677–682.
10.
Hutmacher, D.W., S. Cool (2007) Concepts of scaffold-based tissue engineering – the rationale to use solid free-form fabrication techniques. J Cell Mol Med 11: 654–669.
11.
Jiang, X.Q., X.J. Sun, H.C. Lai, J. Zhao, S.Y. Wang, Z.Y. Zhang (2009) Maxillary sinus floor elevation using a tissue-engineered bone complex with β-TCP and BMP-2 gene-modified bMSCs in rabbits. Clin Oral Implants Res 20: 1333–1340.
12.
Kahnberg, K.E., A. Ekestubbe, K. Grondahl, P. Nilsson, J.M. Hirsch (2001) Sinus lifting procedure. I. One-stage surgery with bone transplant and implants. Clin Oral Implants Res 12: 479–487.
13.
Kempen, D.H., M.C. Kruyt, L. Lu, C.E. Wilson, A.V. Florschutz, L.B. Creemers, M.J. Yaszemski, W.J. Dhert (2009) Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere poly(propylene fumarate) composite. Tissue Eng Part A 15: 587–594.
14.
Kirker Head, C., V. Karageorgiou, S. Hofmann, R. Fajardo, O. Betz, H.P. Merkle, M. Hilbe, B. von Rechenberg, J. McCool, L. Abrahamsen, A. Nazarian, E. Cory, M. Curtis, D. Kaplan, L. Meinel (2007) BMP-silk composite matrices heal critically sized femoral defects. Bone 41: 247–255.
15.
Kroese-Deutman, H.C., P.Q. Ruhe, P.H. Spauwen, J.A. Jansen (2005) Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 26: 1131–1138.
16.
Kuboki, Y., H. Takita, D. Kobayashi, E. Tsuruga, M. Inoue, M. Murata, N. Nagai, Y. Dohi, H. Ohgushi (1998) BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res 39: 190–199.
17.
Liu, C., H. Shao, F. Chen, H. Zheng (2003) Effects of the granularity of raw materials on the hydration and hardening process of calcium phosphate cement. Biomaterials 24: 4103–4113.
18.
Liu, C., Y. Huang, J. Chen (2004) The physicochemical properties of the solidification of calcium phosphate cement. J Biomed Mater Res B Appl Biomater 69: 73–78.
19.
Low, K.L., S.H. Tan, S.H. Zein, J.A. Roether, V. Mouriño, A.R. Boccaccini (2010) Calcium phosphate-based composites as injectable bone substitute materials. J Biomed Mater Res B Appl Biomater 94: 273–286.
20.
Mastrogiacomo, M., S. Scaglione, R. Martinetti, L. Dolcini, F. Beltrame, R. Cancedda, R. Quarto (2006) Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 27: 3230–3237.
21.
Mastrogiacomo, M., A. Papadimitropoulos, A. Cedola, F. Peyrin, P. Giannoni, S.G. Pearce, M. Alini, C. Giannini, A. Guagliardi, R. Cancedda (2007) Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. Biomaterials 28: 1376–1384.
22.
Niedhart, C., U. Maus, E. Redmann, C.H. Siebert (2001) In vivo testing of a new in situ setting beta-tricalcium phosphate cement for osseous reconstruction. J Biomed Mater Res 55: 530–537.
23.
Offer, L., B. Veigel, T. Pavlidis, C. Heiss, M. Gelinsky, A. Reinstorf, S. Wenisch, K.S. Lips, R. Schnettler (2010) Phosphoserine-modified calcium phosphate cements: bioresorption and substitution. J Tissue Eng Regen Med DOI: 10.1002/term.283.
24.
Osyczka, A.M., D.L. Diefenderfer, G. Bhargave, P.S. Leboy (2004) Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176: 109–119.
25.
Potier, E., E. Ferreira, A. Meunier, L. Sedel, D. Logeart-Avramoglou, H. Petite (2007) Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13: 1325–1331.
26.
Rijnen, W.H., J.W. Gardeniers, B.W. Schreurs, P. Buma (2007) Impacted bone and calcium phosphate cement for repair of femoral head defects: a pilot study. Clin Orthop Relat Res 459: 216–221.
27.
Ruhe, P.Q., H.C. Kroese-Deutman, J.G. Wolke, P.H. Spauwen, J.A. Jansen (2004) Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 25: 2123–2132.
28.
Sieron, A.L., N. Louneva, A. Fertala (2002) Site-specific interaction of bone morphogenetic protein 2 with procollagen II. Cytokine 18: 214–221.
29.
Sul, S.H., B.H. Choi, J. Li, S.M. Jeong, F. Xuan (2008) Effects of sinus membrane elevation on bone formation around implants placed in the maxillary sinus cavity: an experimental study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105: 684–687.
30.
Sun, X.J., Z.Y. Zhang, S.Y. Wang, S.A. Gittens, X.Q. Jiang, L.L. Chou (2008) Maxillary sinus floor elevation using tissue-engineered bone complex with OsteoBone and bMSCs in rabbits. Clin Oral Implants Res 19: 804–813.
31.
Triplett, R.G., M. Nevins, R.E. Marx, D.B. Spagnoli, T.W. Oates, P.K. Moy, P.J. Boyne (2009) Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67: 1947–1960.
32.
Wang, L., Y. Huang, K. Pan, X. Jiang, C. Liu (2010) Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann Biomed Eng 38: 77–87.
33.
Wang, S., Z. Zhang, L. Xia, J. Zhao, X. Sun, X. Zhang, D. Ye, H. Uludag, X. Jiang (2010) Systematic evaluation of a tissue-engineered bone for maxillary sinus augmentation in large animal canine model. Bone 46: 91–100.
34.
Weir, M.D., H.H. Xu (2008) High-strength, in situ-setting calcium phosphate composite with protein release. J Biomed Mater Res A 85: 388–396.
35.
Weir, M.D., H.H. Xu (2010) Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue engineering. J Biomed Mater Res A 94: 223–33.
36.
Yang, P., C. Wang, Z. Shi, X. Huang, X. Dang, S. Xu, K. Wang (2009) Prefabrication of vascularized porous three-dimensional scaffold induced from rhVEGF 165: a preliminary study in rats. Cells Tissues Organs 189: 327–337.
37.
Yang, X.B., M.J. Whitaker, W. Sebald, N. Clarke, S.M. Howdle, K.M. Shakesheff, RO. Oreffo (2004) Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 10: 1037–1045.
38.
Yuan, H., Y. Li, J.D. de Bruijn, K. de Groot, X. Zhang (2000) Tissue responses of calcium phosphate cement: a study in dogs. Biomaterials 21: 1283–1290.
39.
Yu, Y.Y., S. Lieu, C. Lu, C. Colnot (2010) Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 47: 65–73.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.